A novel type of protein nanoparticle vaccine formulation containing influenza proteins and adjuvant to boost immune responses has provided complete protection against influenza viral challenges, according to a new study published ...
Bio & Medicine
May 10, 2023
0
78
Newly developed mRNA vaccines against Zika virus and HIV-1 produced strong antibody responses that transferred from pregnant rabbits to their offspring, researchers report in the journal Molecular Therapy. As noted by the ...
Bio & Medicine
Mar 24, 2023
0
49
To many, EV stands for "electric vehicle." To researchers at Harvard University and the University of Nebraska–Lincoln, it's shorthand for another vehicle—this one nanoscopic—that might help streamline the development ...
Bio & Medicine
Jan 30, 2023
0
55
Dengue, a mosquito-borne tropical disease, remains a threat not just in Singapore but in Southeast Asia and beyond. Just this year, Singapore had more than 30,000 cases. Using advanced techniques in cryogenic electron microscopy, ...
Molecular & Computational biology
Dec 7, 2022
0
94
A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics ...
Cell & Microbiology
Jan 19, 2022
0
33
Since the first lab-modified virus capable of replication was generated in 1974, an evidence-based consensus has emerged that many changes introduced into viral genomes are likely to prove unstable if released into the environment. ...
Molecular & Computational biology
Jan 6, 2022
1
383
Viruses such as HIV or the pathogen that causes hepatitis C can overwhelm the immune system. One approach to developing vaccines for these chronic infections has until now been aimed exclusively at what are known as the memory ...
Cell & Microbiology
Dec 13, 2021
0
12
Like expert lock pickers, COVID-19 variants may be more adept at breaking into and infecting human cells, according to new research conducted by FIU physicists.
Cell & Microbiology
Jul 20, 2021
0
374
A mutation in the spike protein of SARS-CoV-2—one of several genetic mutations in the concerning variants that have emerged in the United Kingdom, South Africa, and Brazil—makes the virus up to eight times more infectious ...
Cell & Microbiology
Feb 17, 2021
2
2210
Researchers have used plants to produce virus-like particles (VLPs) of the dengue virus in a potential first step towards novel vaccines against the growing threat.
Biotechnology
Dec 3, 2020
0
39
